it is Rx-only across the US, EU, UK, Canada, and Australia as a GLP-1 agonist
Food and Drug Administration is warning consumers that off-brand forms of the medications could be unsafe
Current plans to end this coverage risk the progress made by patients taking these medications and cast doubt on the future of the [Tricare for Life] benefit, wrote Karen Ruedisueli, director of health affairs in government relations for the Military Officers Association of America, on the nonprofit organizations website
In SURMOUNT-1, 91% lost at least 5%, 79% lost at least 15%, and 36% lost at least 25%
This can lead to eating more calories
Incretin-based therapies work either by preventing enzymatic degradation of GLP-1, thus maintaining plasma levels of endogenous GLP-1 (dipeptidyl peptidase 4 inhibitors, DPP4is) or by directly activating GLP-1 receptors and mimicking the action of native GLP-1 (glucagon-like peptide-1 receptor agonists, GLP-1 RAs) [9]